Business Wire – RegeneRx Awarded Australian Patent for New TB4 Applications

0

July 8, 2010 — HASH(0x2a966b4c10) ROCKVILLE, Md. — RegeneRx Biopharmaceuticals, Inc. (NYSE Amex: RGN) (the âÂ?Â?CompanyâÂ? or…

More: continued here

Filed under Acne Treatments by on #

Leave a Comment

Fields marked by an asterisk (*) are required.

This blog is protected by Dave\\\\\\\'s Spam Karma 2: 18350 Spams eaten and counting...